Grant Detail

About

Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.

Grant Name:

Biomarker and Genomic Testing to Inform Personalized Cancer Diagnosis

Organization:

Conquer Cancer Foundation of the American Society of Clinical Oncology

Date Awarded:

Oct 2020
Amount:

$170,248
Term:

18 months
Grant ID:

GBMF9901
Funding Area:

Patient Care

To support the development of clinical quality measures to improve the diagnosis of ovarian and colorectal cancers.

Related Grants

Conquer Cancer Foundation of the American Society of Clinical Oncology (2)

Organization

Conquer Cancer Foundation of the American Society of Clinical Oncology
- amount
  $422,424
- term
  48 months
Learn More
Title
Quality Measure to Improve Use of Germline Testing in Ovarian, Pancreatic, and Select Breast and Prostate Cancers

Date Awarded
Aug 2023
Organization

Conquer Cancer Foundation of the American Society of Clinical Oncology
- amount
  $170,248
- term
  18 months
Learn More
Title
Biomarker and Genomic Testing to Inform Personalized Cancer Diagnosis

Date Awarded
Oct 2020

date	grant	program	term	amount

date Aug 2023	grant Quality Measure to Improve Use of Germline Testing in Ovarian, Pancreatic, and Select Breast and Prostate Cancers	program Patient Care	term 48 months	amount $422,424

date Oct 2020	grant Biomarker and Genomic Testing to Inform Personalized Cancer Diagnosis	program Patient Care	term 18 months	amount $170,248

Help us spread the word.

Creating positive outcomes for future generations.

Recent News